Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2022 Jul 1;31(7):1473–1482. doi: 10.1158/1055-9965.EPI-22-0007

Figure 2.

Figure 2.

Cumulative incidence functions (CIFs) for developing biochemical recurrence (BCR) or metastatic–lethal events, after accounting for deaths due to other reasons. (a) TCGA, recurrence. (b) TCGA, metastatic-lethal (BCR excluded). (c) FH, recurrence. (d) FH, metastatic-lethal (BCR excluded).